Press ReleaseCardiawave annonce les résultats positifs à 12 mois de ses études “Valvosoft® FIM Study” et « Valvosoft® Pivotal Study » à l’EuroPCR! May 23, 2025 READ MORE
Press ReleaseCardiawave Announces Positive 12-Month Results from Its “Valvosoft® FIM Study” and “Valvosoft® Pivotal Study”, presented at EuroPCR! May 23, 2025 READ MORE
Scientific PublicationsCardiawave’s results published in Journal of Clinical Medicine! Nov 19, 2024 READ MORE
Press ReleaseCardiawave announces positive 6-month data from its Valvosoft Pivotal Study, presented at TCT Conference ! Oct 29, 2024 READ MORE
Press ReleaseCardiawave appoints Olivier Pierron as its Chief Executive Officer Apr 16, 2024 READ MORE
Press ReleaseCardiawave annonce la nomination d’Olivier Pierron en tant que Directeur Général Apr 16, 2024 READ MORE
Press ReleaseCardiawave is presenting the 30-day follow-up results from its “Valvosoft® Pivotal Study” on the treatment of severe symptomatic aortic valve stenosis at the 73rd Annual Conference of the ACC – April 6–8, 2024, Atlanta (GA) Apr 5, 2024 READ MORE
Press ReleaseCardiawave présentera les résultats de suivi à 30 jours de son étude pivot « Valvosoft® Pivotal Study » pour le traitement de la sténose valvulaire aortique sévère symptomatique à la 73ème Conférence annuelle de l’ACC – 6-8 avril 2024 Apr 5, 2024 READ MORE
